| Literature DB >> 29631390 |
Doh Young Lee1, Young Ho Kim1.
Abstract
OBJECTIVES: Smoking is associated with hearing loss, while the correlation between tinnitus and smoking is not fully elucidated. This study aimed to evaluate risk factors of tinnitus in adolescents in terms of smoking, and we identified a rectifiable parameter that can be serially monitored.Entities:
Keywords: Annoyance; Cotinine; Smoking; Tinnitus
Year: 2018 PMID: 29631390 PMCID: PMC6222183 DOI: 10.21053/ceo.2017.01641
Source DB: PubMed Journal: Clin Exp Otorhinolaryngol ISSN: 1976-8710 Impact factor: 3.372
Fig. 1.Study population. a)Not mutually exclusive.
Fig. 2.Prevalence of smoking and tinnitus in each age group. The prevalence of tinnitus increased with age (P<0.001), as did the proportion of smokers (P<0.001), albeit with some fluctuation.
Univariate and multivariate binary logistic regression analysis of risk factors for tinnitus
| Variable | Univariate analysis | Multivariate analysis | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Tinnitus (+) | Tinnitus (-) | OR | 95% CI | OR | 95%CI | VIF | |||
| Age (yr) | 15.1±1.9 | 14.7±2.0 | 0.893 | 0.850-0.938 | <0.001 | 0.958 | 0.860-1.066 | 0.428 | 2.222 |
| Sex (male:female) | 1:1.09 | 1:0.84 | 1.286 | 1.057-1.565 | 0.012 | 1.309 | 0.864-1.983 | 0.203 | 2.212 |
| Body mass index (kg/m2) | 21.15±3.66 | 20.80±3.55 | 0.973 | 0.947-0.999 | 0.045 | 0.968 | 0.930-1.007 | 0.103 | 1.095 |
| Current smoking history | 49 (10.1) | 183 (8.0) | 1.286 | 1.014-1.809 | 0.043 | 1.275 | 0.663-2.450 | 0.467 | 1.197 |
| Parental smoking history | 133 (27.4) | 583 (25.4) | 0.598 | 0.071-2.030 | 0.636 | - | - | - | - |
| Blood test | |||||||||
| Red blood cell (×106/μL) | 4.79±0.41 | 4.85±0.40 | 1.503 | 1.160-1.947 | 0.002 | 1.193 | 0.758-1.878 | 0.445 | 1.698 |
| Hemoglobin (g/dL) | 13.95±1.32 | 13.06±1.28 | 1.072 | 0.990-1.160 | 0.087 | - | - | - | - |
| Hematocrit (%) | 41.60±3.42 | 41.88±3.31 | 1.026 | 0.995-1.058 | 0.106 | - | - | - | - |
| White blood cell (×109/L) | 6.15±1.43 | 6.15±1.42 | 0.997 | 0.928-1.071 | 0.934 | - | - | - | - |
| Blood urea nitrogen (mg/dL) | 11.77±2.66 | 11.73±2.88 | 0.995 | 0.960-1.031 | 0.771 | - | - | - | - |
| Creatinine (mg/dL) | 0.74±0.14 | 0.73±0.14 | 0.812 | 0.400-1.647 | 0.564 | - | - | - | - |
| Glucose (mg/dL) | 88.28±6.31 | 88.95±8.35 | 1.014 | 0.998-1.030 | 0.088 | - | - | - | - |
| Glutamic oxaloacetic transaminase (IU/L) | 17.89±6.02 | 18.41±7.83 | 1.013 | 0.994-1.031 | 0.176 | - | - | - | - |
| Glutamate pyruvate transaminase (IU/L) | 14.89±14.37 | 14.48± 13.27 | 0.998 | 0.991-1.005 | 0.557 | - | - | - | - |
| Triglyceride (mg/dL) | 83.67±42.55 | 85.05±50.94 | 1.001 | 0.998-1.003 | 0.592 | - | - | - | - |
| Total cholesterol (mg/dL) | 156.01±26.77 | 156.07±27.40 | 1.000 | 0.996-1.004 | 0.966 | - | - | - | - |
| High-density lipoprotein (mg/dL) | 49.20±9.04 | 49.47±9.47 | 1.003 | 0.992-1.014 | 0.579 | - | - | - | - |
| Alkaline phosphatase (IU/L) | 460.45±293.33 | 529.94±321.63 | 1.001 | 1.000-1.001 | <0.001 | 1.000 | 0.999-1.001 | 0.779 | 2.713 |
| Pb (μL/dL) | 1.35±0.53 | 0.35±0.48 | 1.015 | 0.674-1.529 | 0.942 | - | - | - | - |
| Hg (ng/mL) | 2.46±1.24 | 2.26±1.22 | 0.887 | 0.762-1.033 | 0.122 | - | - | - | - |
| Cd (ng/mL) | 0.41±0.31 | 0.41±0.25 | 0.816 | 0.393-1.691 | 0.584 | - | - | - | - |
| Urine test | |||||||||
| pH | 5.62±0.70 | 5.60±0.71 | 0.950 | 0.819-1.103 | 0.501 | - | - | - | - |
| Specific gravity | 1.02±0.01 | 1.02±0.01 | 0.304 | 0.000-1.611 | 0.893 | - | - | - | - |
| Protein (mg/dL) | 0.15±0.41 | 0.15±0.41 | 1.042 | 0.799-1.359 | 0.762 | - | - | - | - |
| Ketone (mg/dL) | 0.24±0.58 | 0.23±0.53 | 0.957 | 0.788-1.162 | 0.659 | - | - | - | - |
| Bilirubin (mg/dL) | 0.40±0.80 | 0.38±0.78 | 0.972 | 0.850-1.111 | 0.673 | - | - | - | - |
| Blood | 0.40±0.87 | 0.40±0.84 | 1.006 | 0.886-1.142 | 0.928 | - | - | - | - |
| Bilinogen (mg/dL) | 0.06±0.25 | 0.05±0.23 | 0.853 | 0.559-1.302 | 0.462 | - | - | - | - |
| Cotinine (ng/mL) | 128.76±388.70 | 77.56±276.89 | 1.000 | 0.999-1.000 | 0.018 | 0.999 | 0.999-1.000 | 0.038 | 1.185 |
| Creatinine (mg) | 205.35±92.24 | 201.51 ±89.75 | 1.000 | 0.998-1.000 | 0.575 | - | - | - | - |
Values are presented as mean±standard deviation or number (%).
OR, odds ratio; CI, confidence interval; VIF, variance inflation factor.
Fig. 3.Variation in urine cotinine levels by smoking history (A) and sex (B), and correlation between amount smoked, tinnitus, and tinnitus-related annoyance in smokers (C). (A, B) Participants with tinnitus showed higher urine cotinine levels than those without tinnitus in all subgroups, which reached statistical significance in the total cohort and in smokers and boys. (C) Although development of tinnitus was not associated with the amount smoked, tinnitus-related annoyance was significantly correlated with amount smoked.
Risk factors for tinnitus-related annoyance
| Variable | Tinnitus-related annoyance (+) | Tinnitus-related annoyance (一) | OR | 95% CI | |
|---|---|---|---|---|---|
| Age (yr) | 15.3±2.1 | 15.1±1.9 | 1.051 | 0.927-1.193 | 0.437 |
| Sex (male:female) | 1:1.41 | 1:1.05 | 0.744 | 0.454-1.219 | 0.240 |
| Body mass index (kg/m2) | 20.9±3.5 | 21.2±3.7 | 0.977 | 0.912-1.046 | 0.502 |
| Current smoking history | 8 (10.4) | 40 (9.8) | 1.021 | 0.436-2.392 | 0.962 |
| Alkaline phosphatase (IU/L) | 414.2±241.2 | 471.7±304.1 | 0.999 | 0.998-1.000 | 0.132 |
| Cotinine (ng/mL) | 211.9±606.4 | 107.8±327.7 | 1.001 | 1.000-1.001 | 0.141 |
Values are presented as mean±standard deviation or number (%).
OR, odds ratio; CI, confidence interval.